Likewise, the combination of Topo I inhibitor Irinotecan and Survivin dimerization inhibitor LLP3 results in an upregulation of X-linked inhibitor of apoptosis factor 1 (XAF-1) and downregulation of Survivin in p53-mutated CRC cell lines [156]. Here, BIRC5 is linked to colorectal carcinoma.